CIRAPARANTAG

Search structure
Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UKNOWN
UNII: U2R67KV65Q

Structure
InChI Key HRDUUSCYRPOMSO-ROUUACIJSA-N
Smile N=C(N)NCCC[C@H](N)C(=O)NCCCN1CCN(CCCNC(=O)[C@@H](N)CCCNC(=N)N)CC1
InChI
InChI=1S/C22H48N12O2/c23-17(5-1-7-31-21(25)26)19(35)29-9-3-11-33-13-15-34(16-14-33)12-4-10-30-20(36)18(24)6-2-8-32-22(27)28/h17-18H,1-16,23-24H2,(H,29,35)(H,30,36)(H4,25,26,31)(H4,27,28,32)/t17-,18-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H48N12O2
Molecular Weight 512.71
AlogP -3.2
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 10.0
Number of Rotational Bond 18.0
Polar Surface Area 240.52
Molecular species BASE
Aromatic Rings 0.0
Heavy Atoms 36.0

Pharmacology

Action Mechanism of Action Reference
SEQUESTERING AGENT Apixaban sequestering agent PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Venous Thromboembolism 2 D054556 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3544919
DrugBank DB15199
FDA SRS U2R67KV65Q
SureChEMBL SCHEMBL14985871
CONTENTS